Back to Nephrology

OUR EXPERTISE AND SERVICES AVAILABLE IN

Bone and Mineral Metabolism

Overview

Spherix’s coverage of the bone and mineral metabolism focuses on the complex treatment of secondary hyperparathyroidism (SHPT), vitamin D deficiency, and hyperphosphatemia, tracking treatment trends and the uptake of products as they release into established markets. Covering includes perspective from both nephrologists as well as renal dietitians, and encompasses treatment paradigms for both non-dialysis and dialysis patients.

Services Available

Trending market evolution

  • Bone and Mineral Metabolism (US) - quarterly, n=200

  • Renal Dietitians (US) - semiannual, n=100

Exploring the patient journey

  • Bone and Mineral Metabolism Disorders in CKD Non-Dialysis (US) - n=1,000 patient charts

  • Bone and Mineral Metabolism Disorders in Dialysis (US) - n=1,000 patient charts

  • Bone and Mineral Metabolism Disorders in Incident Dialysis (US) - n=1,000 patient charts

Benchmarking new brand performance

  • Tenapanor (Ardelyx) in Hyperphosphatemia (US)*

*Pending approvals and launch

Gauging impact of disruptive events

  • Multi-Specialty Impact of COVID-19 (US)

Learn more about our services

  • HOW CAN WE PARTNER TOGETHER?

    Get more information on Bone and Mineral Metabolism Coverage